Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1490463

registered interest
date	19/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the average waiting time for mental health treatment.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	901168
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>Last year over 1 million people accessed talking therapies services in the community. We delivered waiting-time promises for adult talking therapies, with 88.8% of people accessing treatment within 6 weeks, and 98.4% within 18 weeks. In April 2022, patients were waiting on average 22.8 days from the point of referral to starting adult talking therapies, nationally.</p><p>For children and young people, we are working towards our aim for 95% accessing eating disorder services within 1 week for urgent cases and 4 weeks for routine cases.</p><p>This year NHS England published consultation outcomes on five new access and waiting time standards for mental health services. We are currently working with NHS England on next steps for implementation.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 19/07/2022 15:54:28 answering member 4680 label Biography information for Gillian Keegan
tabling member	4124 label Biography information for Chi Onwurah

1489336

registered interest
date	14/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many medicines approved by the Medicines and Healthcare products Regulatory Agency under Project Orbis have received a decision on reimbursement by the National Institute for Health and Care Excellence (NICE); and what recent assessment he has made of the adequacy of NICE’s staffing and resourcing capacity.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	36759
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new cancer medicines should be routinely funded by the National Health Service through its technology appraisal programme. NICE has published final technology appraisal guidance on three cancer medicines which have received marketing authorisation from the Medicines and Healthcare products Regulatory Agency through Project Orbis. NICE has also, published final draft guidance on sacituzumab govitecan for treating unresectable locally advanced or metastatic triple-negative breast cancer after two or more therapies, which is now available to NHS patients through the Cancer Drugs Fund.</p><p>The Department holds regular accountability meetings with NICE to discuss a range of issues, such as staffing and resource capacity issues which may impact on NICE’s ability to deliver on its commitments. In 2022/23, NICE plan to increase the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20%, to enable it to respond to the increasing numbers of topics referred for appraisal in a timely manner.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/07/2022 16:34:39 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1489340

registered interest
date	14/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department provides support for people seeking to enrol in an access course to train at university as a nurse.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	36761
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>Financial support is provided by the Department for Education. In the academic year 2022/23, the Department for Education has approved funding for 15 Access to Higher Education Diplomas in Nursing through the Adult Education Budget or Advanced Learner Loans. If a learner then completes an eligible higher education course, the balance of the Advanced Learner Loan for the Access course will be written off.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/07/2022 16:25:43 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1484887

registered interest
date	29/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Newcastle Upon Tyne
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 June 2022 to Question 13119 on Dental Services: North East, if he will make an assessment of whether dentists at NHS Newcastle Gateshead Clinical Commissioning Group have capacity to take on additional patients as on 29 June 2022; and if he will make an estimate of the number of dentists per capita there were in the NHS Newcastle Gateshead Clinical Commissioning Group in the 2010-11 financial year.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	27600
answer	answer is ministerial correction date of answer 19/07/2022 answer text <p>We have no plans to make such an assessment. National Health Service regional teams are responsible for assessing local capacity and commissioning the appropriate NHS dental services. The Department works with NHS England to monitor the delivery of commissioned levels of care in England.</p> answering member constituency Halesowen and Rowley Regis answering member printed James Morris question first answered 19/07/2022 09:28:27 answering member 3992 label Biography information for James Morris
tabling member	4124 label Biography information for Chi Onwurah

1484170

registered interest
date	28/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Racial Discrimination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to improve the complaints procedure for incidents of workplace racism in medical settings, as recommended in the British Medical Association’s report entitled Delivering racial equality in medicine, published in June 2022.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	26763
answer	answer is ministerial correction date of answer 04/07/2022 answer text <p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 25851 question first answered 04/07/2022 14:25:19 answering member 4362 label Biography information for Edward Argar
tabling member	4124 label Biography information for Chi Onwurah

1483631

registered interest
date	27/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Racial Discrimination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the British Medical Association’s report entitled, Delivering racial equality in medicine, what steps he is taking to (a) protect and support medical professionals from racist abuse and (b) help ensure Black and Ethnic Minority groups are not dissuaded from pursuing medical careers.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	25850
answer	answer is ministerial correction date of answer 30/06/2022 answer text <p>The National Health Service Civility and Respect programme aims to tackle discrimination, bullying and harassment in the NHS and to create positive workplace cultures.</p><p>The NHS is improving recruitment processes and career opportunities for all staff, including medical professionals, from ethnic minority backgrounds. The Medical Workforce Racial Equality Standard report in 2020 showed that the number of black and minority ethnic doctors increased by 21.1% compared to 2017. We have accepted the recommendations from the ‘Leadership for a collaborative and inclusive future’ review into health and social care leadership in full. The recommendations include embedding inclusive leadership practice as the responsibility of all and promoting equal opportunity and fairness standards to tackle discrimination.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/06/2022 12:43:12 answering member 4362 label Biography information for Edward Argar
tabling member	4124 label Biography information for Chi Onwurah

1483633

registered interest
date	27/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Racial Discrimination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the recommendation in the British Medical Association’s report entitled, Delivering Racial Equality in Medicine, what steps his Department is taking to help improve the complaints procedure for incidents of workplace racism in medical settings.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	25851
answer	answer is ministerial correction date of answer 04/07/2022 answer text <p>Formal complaints procedures are conducted at individual National Health Service trust and provider level. Through the NHS People Plan, NHS England and NHS Improvement have launched a training programme for Freedom to Speak Up Guardians to improve understanding of inequality experienced by ethnic minority staff and to seek their views.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 26763 question first answered 04/07/2022 14:25:19 answering member 4362 label Biography information for Edward Argar
tabling member	4124 label Biography information for Chi Onwurah

1468907

registered interest
date	09/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Advanced Therapy Medicinal Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Chancellor of the Exchequer on the suitability of the current 3.5 percent discount rate applied for assessing cost effectiveness of Advanced Therapy Medicinal Products (ATMP); and what assessment he has made of the potential merits of lowering this rate to better assess the long-term value and transformative effect of ATMPs.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	15257
answer	answer is ministerial correction date of answer 15/06/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body responsible for the methods and processes used in the development of its guidance and recommendations. NICE recently concluded a comprehensive review of its methods and processes for health technology evaluation, including consideration of the discount rate and published its updated manual on 31 January. Officials from the Department of Health and Social Care and HM Treasury were engaged throughout the review.</p><p>Following a public consultation, NICE concluded that while there was some evidence to support a change to the reference case discount rate, it was appropriate to maintain the existing reference case discount rate of 3.5% due to wider policy and fiscal implications. NICE has retained the flexibility for its committees to apply a lower non-reference case discount rate of 1.5% in exceptional circumstances. This flexibility has previously been applied by NICE when evaluating advanced therapeutic medicinal products, such as its positive appraisal of the gene therapy Zolgensma for the treatment of spinal muscular atrophy.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 15/06/2022 09:57:06 answering member 4362 label Biography information for Edward Argar previous answer version 6254 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4124 label Biography information for Chi Onwurah

1468668

registered interest
date	08/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Advanced Therapy Medicinal Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of increasing the use of the NICE Highly Specialised Technologies evaluation process for Advanced Therapy Medicinal Products to treat a wide range of rare and ultra-rare diseases.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	14485
answer	answer is ministerial correction date of answer 20/06/2022 answer text <p>There are no current plans to do so. The National Institute for Health and Care Excellence (NICE) recently reviewed and refined the criteria used to make decisions on whether medicines should be routed to its highly specialised technology evaluation programme. The updated criteria are not intended to increase or reduce the number of medicines which are evaluated through the highly specialised technologies programme. NICE has recommended 100% of the Advanced Therapy Medicinal Products it has evaluated through both its technology appraisal and highly specialised technologies programmes which are now routinely available to National Health Service patients.</p><p><strong> </strong></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/06/2022 10:26:01 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1468251

registered interest
date	07/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Advertising
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to restrict advertising for foods that are high in fat, sugar or salt to help reduce obesity.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	13711
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>Restrictions on the advertising of products high in fat, salt or sugar (HFSS) on television before 9pm and paid for advertising online will be introduced on 1 January 2024. This will supplement existing restrictions on HFSS advertising during children’s and other programming of particular appeal to children.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 16:32:16 answering member 4447 label Biography information for Maggie Throup
tabling member	4124 label Biography information for Chi Onwurah